日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice

托格列净在日本2型糖尿病患者中的安全性和有效性:一项基于常规临床实践的多中心前瞻性观察研究

Yamada, Yuichiro; Yabe, Daisuke; Shide, Kenichiro; Suzuki, Atsushi; Terauchi, Yasuo; Sato, Yasunori; Shihara, Nobuyuki; Seino, Yutaka

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial)

西格列汀与格列美脲在日本 ≥ 60 岁 2 型糖尿病患者中的疗效和安全性比较(START-J 试验)

Terauchi, Yasuo; Yamada, Yuichiro; Ishida, Hitoshi; Ohsugi, Mitsuru; Kitaoka, Masafumi; Satoh, Jo; Yabe, Daisuke; Shihara, Nobuyuki; Seino, Yutaka

Parturition failure in mice lacking Mamld1

缺乏 Mamld1 的小鼠分娩失败

Mami Miyado, Kenji Miyado, Momori Katsumi, Kazuki Saito, Akihiro Nakamura, Daizou Shihara, Tsutomu Ogata, Maki Fukami

Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression

芳香化酶过量综合征的基因组基础:重组和复制介导的重排导致CYP19A1过表达

Maki Fukami ,Takayoshi Tsuchiya, Heike Vollbach, Kristy A Brown, Shuji Abe, Shigeyuki Ohtsu, Martin Wabitsch, Henry Burger, Evan R Simpson, Akihiro Umezawa, Daizou Shihara, Kazuhiko Nakabayashi, Serdar E Bulun, Makio Shozu, Tsutomu Ogata

Randomized controlled trial of single-agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study

一项针对日本2型糖尿病患者的格列美脲单药治疗与吡格列酮治疗的随机对照试验:比较研究

Shihara, Nobuyuki; Kitaoka, Masafumi; Inagaki, Nobuya; Kadowaki, Takashi; Koumoto, Seisuke; Satoh, Jo; Terauchi, Yasuo; Nunoi, Kiyohide; Yamada, Yuichiro; Sakamaki, Hiroyuki; Seino, Yutaka